SYMKEVI 50 mg/75 mg, film-coated tablet 28 tablets
Active ingredients: Ivacaftor, Tezacaftor
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SYMKEVI 50 mg/75 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) polychlortrifluoroéthylène PVC aluminium de 28 comprimé(s)
- Marketing authorisation holder
- VERTEX PHARMACEUTICALS (IRELAND)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Feb 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62984481CIP73022027CIP133400930220276Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TEZACAFTORcomprimé | 50 mg · un comprimé | SA |
| IVACAFTORcomprimé | 75 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.